News Exelixis, Inc.

Equities

EXEL

US30161Q1040

Market Closed - Nasdaq Other stock markets 04:30:01 2024-05-03 pm EDT			5-day change	1st Jan Change
21.9 ^USD	-0.99%		-6.93%	-8.71%

May. 01	RBC Trims Exelixis' Price Target to $27 From $28, Outperform Rating Kept	MT
Apr. 30	Exelixis Q1 Non-GAAP Earnings, Revenue Rise; 2024 Revenue Guidance Maintained -- Shares Fall After Hours	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

RBC Trims Exelixis' Price Target to $27 From $28, Outperform Rating Kept	May. 01	MT
Exelixis Q1 Non-GAAP Earnings, Revenue Rise; 2024 Revenue Guidance Maintained -- Shares Fall After Hours	Apr. 30	MT
Transcript : Exelixis, Inc., Q1 2024 Earnings Call, Apr 30, 2024	Apr. 30
Exelixis Guides For 2024 Revenue of $1.825-$1.925 Billion, vs CIQ Analyst Consensus of $1.91 Billion	Apr. 30	MT
Earnings Flash (EXEL) EXELIXIS Reports Q1 Revenue $425.2M, vs. Street Est of $460.5M	Apr. 30	MT
Earnings Flash (EXEL) EXELIXIS Reports Q1 EPS $0.17, vs. Street Est of $0.29	Apr. 30	MT
Exelixis: Q1 Earnings Snapshot	Apr. 30	AQ
Exelixis Announces First Quarter 2024 Financial Results and Provides Corporate Update	Apr. 30	BU
Exelixis, Inc. Reaffirms Earnings Guidance for the Year 2024	Apr. 30	CI
Exelixis, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 30	CI
Exelixis to Release First Quarter 2024 Financial Results on Tuesday, April 30, 2024	Apr. 16	BU
North American Morning Briefing : Big Banks Kick -2-	Apr. 12	DJ
Barclays Downgrades Exelixis to Equalweight From Overweight, Price Target is $25	Apr. 11	MT
Jacqueline Wright Notifies Exelixis, Inc. of Her Decision Not to Stand for Re-Election to the Board of Directors	Mar. 29	CI
Transcript : Exelixis, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-13-2024 10:45 AM	Mar. 13
Transcript : Exelixis, Inc. Presents at Leerink Partners Global Biopharma Conference 2024, Mar-12-2024 09:20 AM	Mar. 12
Transcript : Exelixis, Inc. Presents at TD Cowen 44th Annual Health Care Conference 2024, Mar-05-2024 10:30 AM	Mar. 05
Exelixis to Webcast Fireside Chats as Part of Investor Conferences in March	Feb. 27	BU
BioInvent International AB Year-end report January 1, December 31, 2023	Feb. 23	AQ
Exelixis Insider Bought Shares Worth $3,932,734, According to a Recent SEC Filing	Feb. 22	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Exelixis, Inc.

Equities

EXEL

US30161Q1040

Summary

Filters